Keith D. Kaufman

Statistics

Publications

Citations

11.4K

H-Index

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California, San Francisco

Duke University

University of Oxford

Oxford Centre for Diabetes, Endocrinology and Metabolism

Keith D. Kaufman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacotherapy, and clinical pharmacology.

ORCID

Publications per year

1987–2025

Publications

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Finasteride in the treatment of men with androgenetic alopecia

Keith D. Kaufman, Elise A. Olsen, David Whiting et al. · Journal of the American Academy of Dermatology · 1998 · 765 citations

Medicine, Dermatology, Pharmacotherapy +7

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Yuji Nagayama, Keith D. Kaufman, Pui Seto et al. · Biochemical and Biophysical Research Communications · 1989 · 523 citations

Life Sciences, Genetics, Molecular Biology +7

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen et al. · Diabetes Obesity and Metabolism · 2009 · 305 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Itamar Raz, Yu Chen, Mei Wu et al. · Current Medical Research and Opinion · 2008 · 262 citations

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 99